Predictors of death in adults with duchenne muscular dystrophy-associated cardiomyopathy
The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Background: Duchenne muscular dystrophy ( DMD ) is frequently complicated by development of a cardiomyopathy. Despite significant medical advances provided to DMD patients over the past 2 decades, there remains a group of DMD patients who die prematurely. The current study sought to identify a set of prognostic factors that portend a worse outcome among adult DMD patients. Methods and Results: A retrospective cohort of 43 consecutive patients was followed in the adult UT Southwestern Neuromuscular Cardiomyopathy Clinic. Clinical data were abstracted from the electronic medical record to generate baseline characteristics. The population was stratified by survival to time of analysis and compared with characteristics associated with death. The DMD population was in the early 20s, with median follow‐up times over 2 years. All the patients had developed a cardiomyopathy, with the majority of the patients on angiotensin‐converting enzyme inhibitors (86%) and steroids (56%), but few other guideline‐directed heart failure medications. Comparison between the nonsurviving and surviving cohorts found several poor prognostic factors, including lower body mass index (17.3 [14.8–19.3] versus 25.8 [20.8–29.1] kg/m 2 , P <0.01), alanine aminotransferase levels (26 [18–42] versus 53 [37–81] units/L, P =0.001), maximum inspiratory pressures (13 [0–30] versus 33 [25–40] cmH 2 O, P =0.03), and elevated cardiac biomarkers (N‐terminal pro‐brain natriuretic peptide: 288 [72–1632] versus 35 [21–135] pg/mL, P =0.03]. Conclusions: The findings demonstrate a DMD population with a high burden of cardiomyopathy. The nonsurviving cohort was comparatively underweight, and had worse respiratory profiles and elevated cardiac biomarkers. Collectively, these factors highlight a high‐risk cardiovascular population with a worse prognosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hypotension, as a result of shock, is associated with conditions such as stroke, cardiac arrest and respiratory failure, which are among the most common causes of death in DMD (Winterholler et al., 2016; Cheeran et al., 2017).”
From Understanding Duchenne muscular dystrophy-associated brain pathology (2025) · cites this paper as Cheeran et al., 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Interpretative strategies for lung function tests
Pellegrino, R., Viegi, G., Brusasco, V., Crapo, R. O., Burgos, F., Casaburi, R., Coates, A., van der Grinten, C. P. M., Gustafsson, P., Hankinson, J., et al. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00035205 · Cited by 5,945
Emery, A. E. (2002) · The Lancet · doi:10.1016/s0140-6736(02)07815-7 · Cited by 1,667
Corticosteroids for the treatment of Duchenne muscular dystrophy
Matthews, E., Brassington, R., Kuntzer, T., Jichi, F., & Manzur, A. Y. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003725.pub4 · Cited by 493
Aladin, A. I., Whelton, S. P., Al-Mallah, M. H., Blaha, M. J., Keteyian, S. J., Juraschek, S. P., Rubin, J., Brawner, C. A., & Michos, E. D. (2014) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2014.08.042 · Cited by 70 · cited 1×
“Median heart rate (96 bpm [82–108]) was close to the upper limit of the accepted normal range.(27,28) Most patients were on angiotensin-converting enzyme inhibitors or angiotensin II receptor blocker therapy (86%) on arrival to the clinic, but only about a third of patients were receiving b-blockers (37%).”
Background
Research works printed but not linked: 36
- 10.1016/S0960-8966(02)00140-2 · DOI · Paper page
- Passamano L, Taglia A, Palladino A, Viggiano E, D'Ambrosio P, Scutifero M, Rosaria Cecio M, Torre V, De Luca F, Picillo E, Paciello O, Piluso G, Nigro G, Politano L. Improvement of survival in Duchenne muscular dystrophy: retrospective analysis of 835 patients. Acta Myol. 2012;31:121–125.
- 10.1016/0167-5273(90)90082-G · DOI · Paper page
- 10.1016/S1474-4422(09)70272-8 · DOI · Paper page
- 10.1161/CIRCULATIONAHA.114.015151 · DOI · Paper page
- 10.1016/S1474-4422(09)70271-6 · DOI · Paper page
- 10.1016/j.jacc.2004.09.078 · DOI
- 10.1016/j.ahj.2007.05.014 · DOI · Paper page
- 10.1016/j.amjcard.2012.02.064 · DOI · Paper page
- 10.1001/jamacardio.2016.4801 · DOI
- 10.1371/currents.md.2cc69a1dae4be7dfe2bcb420024ea865 · doi:10.1371/currents.md.2cc69a1dae4be7dfe2bcb420024ea865
- 10.1253/circj.70.991 · DOI
- 10.2169/internalmedicine.49.3259 · DOI
- 10.1016/S1474-4422(14)70318-7 · DOI · Paper page
- 10.1056/NEJM198906153202405 · DOI · Paper page
- 10.1016/j.jacc.2012.12.008 · DOI · Paper page
- 10.1016/j.jacc.2012.12.011 · doi:10.1016/j.jacc.2012.12.011
- 10.1016/j.healun.2009.08.030 · DOI
- 10.1097/MAT.0000000000000050 · doi:10.1097/mat.0000000000000050
- 10.1002/ehf2.12160 · doi:10.1002/ehf2.12160
- 10.1002/mus.24163 · DOI
- 10.1016/j.echo.2014.10.003 · DOI · Paper page
- 10.1016/j.jacc.2011.01.049 · DOI · Paper page
- 10.1016/j.hrthm.2005.09.008 · DOI · Paper page
- 10.1016/j.jelectrocard.2006.09.003 · DOI · Paper page
- 10.1111/j.1751-7133.2011.00250.x · DOI · Paper page
- 10.1016/j.jacc.2006.10.078 · DOI · Paper page
- 10.1016/j.jacc.2013.05.019 · DOI · Paper page
- 10.1155/2015/543282 · DOI
- 10.1542/peds.2010-0929 · DOI
- LoMauro A, D'Angelo MG, Aliverti A. Assessment and management of respiratory function in patients with Duchenne muscular dystrophy: current and emerging options. Ther Clin Risk Manag. 2015;11:1475–1488.
- 10.1007/s10741-014-9442-y · DOI · Paper page
- 10.1016/S0140-6736(96)07015-8 · DOI · Paper page
- 10.1016/j.jchf.2013.01.006 · DOI · Paper page
- 10.1016/j.hfc.2013.12.002 · DOI
- 10.1093/ageing/afv129 · DOI
Cited by
Mercuri, E., Bönnemann, C. G., & Muntoni, F. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32910-1 · Cited by 551
Understanding Duchenne muscular dystrophy-associated brain pathology
Verhaeg, M. A. T., Govaarts, R., & van Putten, M. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052302 · Cited by 5
Metadata
- Authors
- Cheeran, D., Khan, S., Khera, R., Bhatt, A., Garg, S., Grodin, J. L., Morlend, R., Araj, F. G., Amin, A. A., Thibodeau, J. T., Das, S., Drazner, M. H., & Mammen, P. P. A.
- Affiliations
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX
- Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX
- Venue
- Journal of the American Heart Association
- Published
- 2017-10-11
- Volume
- 6
- Issue
- 10
- ISSN
- 2047-9980
- Cited by
- 75
- References
- 4
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Predictors of death in adults with duchenne muscular dystrophy-associated cardiomyopathy. https://app.cochat.ai/papers/10.1161/jaha.117.006340
- The paper
- Cheeran, D., Khan, S., Khera, R., Bhatt, A., Garg, S., Grodin, J. L., Morlend, R., Araj, F. G., Amin, A. A., Thibodeau, J. T., Das, S., Drazner, M. H., & Mammen, P. P. A. (2017). Predictors of death in adults with duchenne muscular dystrophy-associated cardiomyopathy. Journal of the American Heart Association. https://doi.org/10.1161/jaha.117.006340
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.